Temozolomide suspension (Orphelia Pharma)
N/A
Report date: 2024/05/11 18:33:39
Base Information
Drug NameTemozolomide suspension (Orphelia Pharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesOrphelia Pharma
China Registration ClassN/A
Develop Information
Active CompaniesTanner Pharma GroupOrphelia Pharma
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A